Clinical Trial

Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms

Study acronym: MUSA3
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study/research is to assess the relationship between ultrasound features of the myometrium suggestive of adenomyosis and clinical symptoms of adenomyosis and to establish a reporting system for adenomyosis assessing disease severity. Consecutive pre- and perimenopausal symptomatic and asymptomicasymptomatic women with an uterus presenting for gynaecological ultrasound exams will be asked to participate in the study. Routine gynecologicalgynaecological ultrasound exams will be performed and study participants will fill out a questionnaire on their symptoms (if any) and bleeding pattern. There will be one visit and no interventions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-05.
Trial Details
NCT Number NCT07397715
Lead Sponsor Swiss GO Trial Group
Collaborators: University Hospital, Basel, Switzerland
Conditions Adenomyosis of Uterus
Enrollment 1,000 participants
Start Date 2024-03-15
Primary Completion 2028-02-01 (estimated)
Study Completion 2029-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12